The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes

Diabetes Care

Volumn 31, Issue 8, 2008, Pages 1546-1549

  Fourlanos, Spiros ^a,b   Varney, Michael D ^c   Tait, Brian D ^c   Morahan, Grant ^d   Honeyman, Margo C ^a   Colman, Peter G ^b   Harrison, Leonard C ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c Victorian Transplantation and Immunogenetics Service   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A11 ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN;

ARTICLE; CHILD; CHILDBIRTH; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; SCHOOL CHILD; ADOLESCENT; AUSTRALIA; CAUCASIAN; ENVIRONMENT; GENETICS; IMMUNOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; ENVIRONMENT; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; INCIDENCE; POLYMERASE CHAIN REACTION; RISK FACTORS; VICTORIA;

EID: 49649104814     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0239     Document Type: Article

References (22)

1. Eisenbarth GS: Update in type 1 diabetes. J Clin Endocrinol Metab 92:2403-2407, 2007
2. Eisenbarth GS: Type 1 Diabetes: Molecular, Cellular and Clinical Immunology. 2.5 ed. Eisenbarth GS, Ed. Denver, CO, The Barbara Davis Center for Childhood Diabetes, 2007
3. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JH, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B, Burren OS, Lam AA, Ovington NR, Allen J, Adlem E, Leung HT, Wallace C, Howson JM, Guja C, Ionescu-Ttrgoviste C, Genetics of Type 1 Diabetes in Finland, Simmonds MJ, Heward JM, Gough SC, Dunger DB, Wicker LS, Clayton DG, the Wellcome Trust Case Control Consortium: Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857-864, 2007
4. Gale EA: The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353-3361, 2002
5. The DIAMOND Project Group: Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 23:857-866, 2006
6. Gillespie KM, Bain SC, Barnett AH, Bing- ley PJ, Christie MR, Gill GV, Gale EA: The rising incidence of childhood type 1 diabetes and reduced contribution of high- risk HLA haplotypes. Lancet 364:1699 - 1700, 2004
7. Hermann R, Knip M, Veijola R, Simell O, Laine AP, Akerblom HK, Groop PH, Forsblom C, Pettersson-Fernholm K, Ilonen J: Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes: indication of an increased environmental pressure? Diabetologia 46:420 -425, 2003
8. Marks HH: Longevity and mortality of diabetics. Am J Public Health 55:416-423, 1965
9. McNally PG, Raymond NT, Burden ML, Burton PR, Botha JL, Swift PG, Burden AC, Hearnshaw JR: Trends in mortality of childhood-onset insulin-dependent diabetes mellitus in Leicestershire: 1940-1991. Diabet Med 12:961-966, 1995
10. Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, Orchard TJ: Mortality trends in type 1 diabetes: the Allegheny County (Pennsylvania) Registry 1965-1999. Diabetes Care 24:823-827, 2001
11. Morahan G, Huang D, Ymer SI, Cancilla MR, Stephen K, Dabadghao P, Werther G, Tait BD, Harrison LC, Colman PG: Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 27:218-221, 2001
12. Tait BD, Colman PG, Morahan G, Marchinovska L, Dore E, Gellert S, Honeyman MC, Stephen K, Loth A: HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 61:146-153, 2003
13. Kimura A, Sasazuki T: Eleventh International Histocompatibility Workshop Reference Protocol for the HLA DNA-Typing Technique. Oxford, Oxford University Press, 1992
14. Haynes A, Bower C, Bulsara MK, Jones TW, Davis EA: Continued increase in the incidence of childhood type 1 diabetes in a population-based Australian sample (1985-2002). Diabetologia 47:866-870, 2004
15. Tuomi T, Carlsson A, Li H, Isomaa B, Mi- ettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157, 1999
16. Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC: Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206 -2212, 2005
17. Bishop RF, Cameron DJ, Veenstra AA, Barnes GL: Diarrhoea and rotavirus infection associated with differing regimens for postnatal care of newborn infants. J Clin Microbiol 9:525-529, 1979
18. Harrison LC, Honeyman MC: Mucosa, not moocosa! In Commentaries on Perspectives in Diabetes: 1988-1992. Vol. 3. Robertson RP, Ed. American Diabetes Association, Alexandria, VA, 2006, p. 158
19. Honeyman MC Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele CE, Couper JJ, Tait BD, Colman PG, Harrison LC: Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49:1319-1324, 2000
20. Norton K, Dollman J, Martin M, Harten N: Descriptive epidemiology of childhood overweight and obesity in Australia: 1901-2003. Int J Pediatr 1:232-238, 2006
21. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC: Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661-1667, 2004
22. Pickup JC: Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813-823, 2004